Contemporary risk profile of prostate cancer in the United States

Yu Hsuan Shao, Kitaw Demissie, Weichung Shih, Amit R. Mehta, Mark N. Stein, Calpurnyia B. Roberts, Robert S. Dipaola, Grace L. Lu-Yao

Research output: Contribution to journalArticle

199 Citations (Scopus)

Abstract

National-level data that characterize contemporary prostate cancer patients are limited. We used 2004-2005 data from the Surveillance, Epidemiology, and End Results Program to generate a contemporary profile of prostate cancer patients (N = 82541) and compared patient characteristics of this 2004-2005 population with those of patients diagnosed in 1998-1989 and 1996-1997. Among newly diagnosed patients in 2004-2005, the majority (94%) had localized (ie, stage T1 or T2) prostate cancer and a median serum prostate-specific antigen (PSA) level of 6.7 ng/mL. Between 1988-1989 and 2004-2005, the average age at prostate cancer diagnosis decreased from 72.2 to 67.2 years, and the incidence rate of T3 or T4 cancer decreased from 52.7 per 100000 to 7.9 per 100000 among whites and from 90.9 per 100000 to 13.3 per 100000 among blacks. In 2004-2005, compared with whites, blacks were more likely to be diagnosed at a younger age (mean age: 64.7 vs 67.5 years, difference = 2.7 years, 95% confidence interval [CI] = 2.5 to 2.9 years, P

Original languageEnglish
Pages (from-to)1280-1283
Number of pages4
JournalJournal of the National Cancer Institute
Volume101
Issue number18
DOIs
Publication statusPublished - Sep 2009
Externally publishedYes

Fingerprint

Prostatic Neoplasms
SEER Program
Prostate-Specific Antigen
Confidence Intervals
Incidence
Serum
Population
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Shao, Y. H., Demissie, K., Shih, W., Mehta, A. R., Stein, M. N., Roberts, C. B., ... Lu-Yao, G. L. (2009). Contemporary risk profile of prostate cancer in the United States. Journal of the National Cancer Institute, 101(18), 1280-1283. https://doi.org/10.1093/jnci/djp262

Contemporary risk profile of prostate cancer in the United States. / Shao, Yu Hsuan; Demissie, Kitaw; Shih, Weichung; Mehta, Amit R.; Stein, Mark N.; Roberts, Calpurnyia B.; Dipaola, Robert S.; Lu-Yao, Grace L.

In: Journal of the National Cancer Institute, Vol. 101, No. 18, 09.2009, p. 1280-1283.

Research output: Contribution to journalArticle

Shao, YH, Demissie, K, Shih, W, Mehta, AR, Stein, MN, Roberts, CB, Dipaola, RS & Lu-Yao, GL 2009, 'Contemporary risk profile of prostate cancer in the United States', Journal of the National Cancer Institute, vol. 101, no. 18, pp. 1280-1283. https://doi.org/10.1093/jnci/djp262
Shao, Yu Hsuan ; Demissie, Kitaw ; Shih, Weichung ; Mehta, Amit R. ; Stein, Mark N. ; Roberts, Calpurnyia B. ; Dipaola, Robert S. ; Lu-Yao, Grace L. / Contemporary risk profile of prostate cancer in the United States. In: Journal of the National Cancer Institute. 2009 ; Vol. 101, No. 18. pp. 1280-1283.
@article{50a1d30641844e218ec4da31cb2727b4,
title = "Contemporary risk profile of prostate cancer in the United States",
abstract = "National-level data that characterize contemporary prostate cancer patients are limited. We used 2004-2005 data from the Surveillance, Epidemiology, and End Results Program to generate a contemporary profile of prostate cancer patients (N = 82541) and compared patient characteristics of this 2004-2005 population with those of patients diagnosed in 1998-1989 and 1996-1997. Among newly diagnosed patients in 2004-2005, the majority (94{\%}) had localized (ie, stage T1 or T2) prostate cancer and a median serum prostate-specific antigen (PSA) level of 6.7 ng/mL. Between 1988-1989 and 2004-2005, the average age at prostate cancer diagnosis decreased from 72.2 to 67.2 years, and the incidence rate of T3 or T4 cancer decreased from 52.7 per 100000 to 7.9 per 100000 among whites and from 90.9 per 100000 to 13.3 per 100000 among blacks. In 2004-2005, compared with whites, blacks were more likely to be diagnosed at a younger age (mean age: 64.7 vs 67.5 years, difference = 2.7 years, 95{\%} confidence interval [CI] = 2.5 to 2.9 years, P",
author = "Shao, {Yu Hsuan} and Kitaw Demissie and Weichung Shih and Mehta, {Amit R.} and Stein, {Mark N.} and Roberts, {Calpurnyia B.} and Dipaola, {Robert S.} and Lu-Yao, {Grace L.}",
year = "2009",
month = "9",
doi = "10.1093/jnci/djp262",
language = "English",
volume = "101",
pages = "1280--1283",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "18",

}

TY - JOUR

T1 - Contemporary risk profile of prostate cancer in the United States

AU - Shao, Yu Hsuan

AU - Demissie, Kitaw

AU - Shih, Weichung

AU - Mehta, Amit R.

AU - Stein, Mark N.

AU - Roberts, Calpurnyia B.

AU - Dipaola, Robert S.

AU - Lu-Yao, Grace L.

PY - 2009/9

Y1 - 2009/9

N2 - National-level data that characterize contemporary prostate cancer patients are limited. We used 2004-2005 data from the Surveillance, Epidemiology, and End Results Program to generate a contemporary profile of prostate cancer patients (N = 82541) and compared patient characteristics of this 2004-2005 population with those of patients diagnosed in 1998-1989 and 1996-1997. Among newly diagnosed patients in 2004-2005, the majority (94%) had localized (ie, stage T1 or T2) prostate cancer and a median serum prostate-specific antigen (PSA) level of 6.7 ng/mL. Between 1988-1989 and 2004-2005, the average age at prostate cancer diagnosis decreased from 72.2 to 67.2 years, and the incidence rate of T3 or T4 cancer decreased from 52.7 per 100000 to 7.9 per 100000 among whites and from 90.9 per 100000 to 13.3 per 100000 among blacks. In 2004-2005, compared with whites, blacks were more likely to be diagnosed at a younger age (mean age: 64.7 vs 67.5 years, difference = 2.7 years, 95% confidence interval [CI] = 2.5 to 2.9 years, P

AB - National-level data that characterize contemporary prostate cancer patients are limited. We used 2004-2005 data from the Surveillance, Epidemiology, and End Results Program to generate a contemporary profile of prostate cancer patients (N = 82541) and compared patient characteristics of this 2004-2005 population with those of patients diagnosed in 1998-1989 and 1996-1997. Among newly diagnosed patients in 2004-2005, the majority (94%) had localized (ie, stage T1 or T2) prostate cancer and a median serum prostate-specific antigen (PSA) level of 6.7 ng/mL. Between 1988-1989 and 2004-2005, the average age at prostate cancer diagnosis decreased from 72.2 to 67.2 years, and the incidence rate of T3 or T4 cancer decreased from 52.7 per 100000 to 7.9 per 100000 among whites and from 90.9 per 100000 to 13.3 per 100000 among blacks. In 2004-2005, compared with whites, blacks were more likely to be diagnosed at a younger age (mean age: 64.7 vs 67.5 years, difference = 2.7 years, 95% confidence interval [CI] = 2.5 to 2.9 years, P

UR - http://www.scopus.com/inward/record.url?scp=70349231253&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349231253&partnerID=8YFLogxK

U2 - 10.1093/jnci/djp262

DO - 10.1093/jnci/djp262

M3 - Article

VL - 101

SP - 1280

EP - 1283

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 18

ER -